Pfizer would rather miss out on billions of dollars of guaranteed profit selling mRNA in India
— William Makis MD (@MakisMD) February 12, 2022
than submit to an independent local trial to:
"determine if the vaccine is SAFE and generates an immune response in its citizens"
Let this sink in.#ableghttps://t.co/Zkd4ecz5RY